We investigate the problem of extracting mentions of medications and adverse drug events using sequence labelling and nonsequence labelling methods. We experiment with three different methods on two different datasets, one from a patient forum with noisy text and one containing narrative patient records. An analysis of the output from these methods are reported to identify what types of named entities are best identified using these methods and, more specifically, how well the discontinuous and overlapping entities that are prevalent in our forum dataset are identified. Our findings can guide studies to choose different methods based on the complexity of the named entities involved, in particular in text mining for pharmacovigilance.
Introduction
An Adverse Drug Reaction (ADR) is an injury occurring after a drug (medication) is used at the recommended dosage, for recommended symptoms. The practice of monitoring the ADRs of pharmaceutical products is known as pharmacovigilance [Alghabban, 2004] . Different from controlled clinical trials which are mainly conducted before drugs are licensed for use, pharmacovigilance is especially concerned with identifying previously unreported adverse reactions. Text mining over different sources of information, such as electronic health records and patient reports on health forums, can be one way of finding such potential adverse reactions. This is the area to which our work contributes. We note that when causality between an adverse reaction and a medication is not known, it is referred to as Adverse Drug Event (ADE) [Karimi et al., 2015c] .
Extracting mentions of drugs and adverse events from social media is difficult for two main reasons. First, social media text contains colloquial language and typographical mistakes. References to the names of drugs, diseases, and ADEs are particularly prone to misspellings. Second, a medical concept can be considered both an ADE or a symptom in different contexts. For example, aches and pains is a symptom in the context of "I am only taking 75 mg a day and it is wonderful for relieving all of my aches and pains", while it is an ADE in another post complaining of severe fatigue with aches and pains. We cast this concept extraction problem as a supervised Named Entity Recognition (NER) task, with drugs and ADEs as entity types.
Named entity recognition itself has long been studied in different domains, including the biomedical domain. There are a number of challenges that are associated with how named entities are expressed in text. These include entities expressed as multiwords, especially if the entities are overlapping, discontinuous, or nested. Table 1 lists some examples of entity types of different complexities. Entities that consist of a discontinuous sequence of tokens are one of the more challenging ones to recognise correctly, yet they constitute a large portion (over 10%) of adverse event mentions in the forum posts that we studied.
We are interested in the extraction of two named entities from free-text: medications or drugs, and adverse drug events. We divide named entities into two sets of complex and simple entities. Complex entities are those belonging to one of the categories of nested, discontinuous, and overlapping entities. Multiword entities that are continuous are also more difficult to identify than the single word ones. We therefore refer to the entities that are single words, as simple regardless of what class of entity, drug or ADE, they represent. Extraction of complex entities is particularly important in the biomedical domain where these entities are more popular [Kilicoglu et al., 2016] . In this paper, we evaluate three NER methods, one most popular and two most recent ones, for their capabilities in extracting the complex entities that exist in our noisy dataset of reports of adverse drug events. Our aim is to identify which of these methods more accurately extracts these entities, and whether the differences in complexity or type of entities guide what method to choose.
Related Work
Related studies are categorised into two: (1) methods for named entity recognition, both in general and in the biomedical area, and (2) approaches to concept extraction for pharmacovigilance. NER has a very long history in the area of natural language processing, going back to early 90s and information extraction tasks in the Message Understanding Conferences. Below we only review those methods that are directly relevant to our work. Concept extraction in the biomedical area also has been studied extensively, with some of the early work for biological concepts such as genes and proteins in the context of GENIA [Ohta et al., 2002] . We only review a subset of these, focusing on medications and their adverse events.
Named Entity Recognition
Named Entity Recognition (NER), the problem of identifying named entities in free-text, was originally and long focused on entity classes of person, location, organisation, and time. It then expanded to a large variety of entities, depending on the application domains, including biomedical [Ramakrishnan et al., 2008 , Leaman and Gonzalez, 2008 , Verspoor et al., 2012 and social media [Ritter et al., 2011] .
NER is traditionally seen as a sequence labelling task. One of the most competitive models is Conditional Random Fields (CRF). It is applied in a number of NER systems, such as Stanford NER. Finkel et al. [2005] , who propose one of the methods underlying Stanford NER, modify CRF by adding non-local structure using Gibbs sampling. This method maintains a sequence model structure and, at the same time, adds long-distance conditioning influences. This way, there is no need to enforce no-overlap constraints as some of the other NER methods do. We note that, in the biomedical domain, similar CRF-based NER tools have been developed that incorporate some of the biomedical ontologies. BANNER [Leaman and Gonzalez, 2008] is one example of such publicly available tools.
In one of the early studies where the complexity of named entities is specifically investigated, Downey et al. [2007] propose a Web NER method to locate a diverse set of entities that can be found from the web. They consider the task of NER as an n-gram detection of multiword units. Their method starts unsupervised and therefore does not bound itself to pre-defined entities. It then uses CRFs and Conditional Markov Models, and is tested on both simple and complex named entities. In that work, complex named entities are defined as entities such as names of books and movies, where then baseline systems used to fail. Their proposed method, called LEX, is particularly high performing for finding the continuous multiword entities on web pages since it is designed for such cases.
In the biomedical domain, entities can be complicated. Ramakrishnan et al. [2008] highlight the problem of dealing with compound entities which they define as those NEs that are composed of simpler entities, such as names of diseases, body parts, processes and substances. Another class of complex entities is nested entities which has received attention from the biomedical NLP community. Alex et al. [2007] study nested and discontinuous entities in the biomedical domain in the context of two corpora: GENIA [Ohta et al., 2002] and BioInfer [Pyysalo et al., 2007] . For example, the name of a DNA can be nested inside the name of an RNA protein. Alex et al. [2007] identify the problem to be how NEs used to be represented using the IOB (Inside, Outside, Beginning) representation. This representation does not allow tokens to belong to more than one entity. They experiment with extending this representation as well as with cascading and joint learning models. Their method, however, is unable to identify nested entities of the same type. Finkel and Manning [2009] propose a discriminative parsingbased method for nested named entity recognition, employing CRFs as its core. Kilicoglu et al. [2016] identify the lack of training data for NER in biomedical domain for consumer health questions. They create an annotated corpus where entities can be ambiguous by having multiple types, being nested, multi-part or discontinuous. They recognise the problem of evaluating systems using some of these entity types and provide some recommendations on how to deal with them by using different entity representations.
Most recently, neural networks have been applied to the NER task. Crichton et al. [2017] investigate NER in biomedical area using convolutional neural networks. They experiment with a variety of models-such as single-task, multi-task, dependent multi-task and multi-output models-on 15 different datasets. They show that, on average, multi-task models were superior to singletask ones. Liu et al. [2017] investigate entity recognition from the Informatics on the Integrating Biology and the Bedside (i2b2) corpora (2010, 2012 , and 2014 NLP challenges) using Long-Short Term Memory (LSTM). For the concept extraction task of the i2b2 challenge 2010, they show improvements over CRF methods using an LSTM-based method that uses character embeddings. NEs are represented using BIOES (B-beginning of an entity, I-insider of an entity, O-outsider of an entity, E-end of an entity, S-a single-token entity). This is close to one of the methods we use in our work. However they do not provide any insight on extracting complex entities (if there were any) in their datasets.
Concept Extraction for Pharmacovigilance
Safety signal detection for pharmacovigilance from medical literature, electronic health records and medical forums have been studied in the past decade [Kuhn et al., 2010 , Leaman et al., 2010 , Benton et al., 2011 , Liu and Chen, 2013 , Karimi et al., 2015c , Zhao et al., 2015 , Pierce et al., 2017 . One of the problems in generating such signals from text is the extraction of relevant concepts, such as medications, adverse events, and patient information. Named entity recognition therefore has been studied as one of the methods to extract these relevant concepts. Nikfarjam et al. [2015] investigate ADE extraction from a medical forum, DailyStrength, and Twitter, using Conditional Random Fields (CRFs). To train the CRFs, they use word embeddings as one of the features created based on the forum and Twitter data. The entity representation method in their study is IOB (Inside, Outside, and Beginning). consider ADE extraction as a classification task using multiple corpora: a patient forum, Twitter, and medical case reports. They use these datasets for training classifiers, including SVM, Maximum Entropy and Naïve Bayes. The combination of different corpora for training leads to improved classification accuracy. Klein et al. [2017] also extend the work by providing classification baselines as well as making the Twitter data available for further research. This dataset however does not contain discontinuous, overlapping or nested entities and therefore is not used in our study. Another problem with using the Twitter dataset is that it changes as based on the availability of tweets at the time of crawling, making it difficult for comparisons of the reported results in the literature.
[ Karimi et al., 2015b, Metke-Jimenez and Karimi, 2016] investigate both dictionary-based and machine learning approaches based on CRFs for the identification of medical concepts, including drugs and ADEs. Their CRF models outperform most lexicon-based methods popular in this domain on a corpus from medical forums, called CADEC [Karimi et al., 2015a] . They argue that some of the discontinuous entities in the corpus are responsible for a portion of their errors. Cocos et al. [2017] develop an BiLSTM model that used word embeddings from a large Twitter corpus to identify ADEs in tweets. They compare their method to CRFs (from CRFSuite software [Okazaki, 2007] ) and lexicon-based methods showing improvements using BiLSTMs. We note improvements are seen in recall values, as opposed to higher precision that is achieved using CRFs. Their experiments show that static semantic information learned from a large, generic dataset through word embeddings is the only setting in BiLSTM that leads to higher F-Score. Since their focus is not on identifying complex entities such as discontinuous ones, they use a straightforward IO schema (Inside, Outside) for representing the named entities. Their error analysis identifies constituent phrases (multiword ADEs) as one source of errors made by their method.
Datasets
We use two datasets for our evaluations: CADEC [Karimi et al., 2015a] and the i2b2 2009 medication challenge [Uzuner et al., 2010] . CADEC consists of 1,250 posts from the medical forum AskaPatient. These posts were manually annotated by medical experts and a clinical terminologist for drugs, ADEs, diseases, symptoms, and findings. Among all 9,111 annotated entities, there are 1,800 drug entities and 6,318 ADE entities. The rest of the entities are ignored in this study. Table 2 lists the overall statistics of the entities in the two datasets. In CADEC, many of the entities, especially ADEs, consist of discontinuous and overlapping spans. Different from other NER corpus, where the longest possible spans are identified as single entities, CADEC has many finegrained entities, each of which can be referred to a specific medical concept in medicine terminology vocabularies. For example, in the sentence Pain in hip, lower back, knees & elbow, there are four ADEs: Pain in lower back, Pain in knees, Pain in elbow, and Pain in hip, corresponding to four different concepts in SNOMED Clinical Terms (SNOMED CT) 1 .
The i2b2 medication extraction challenge dataset focuses on the identification of medications and medication-related information, such as 1 https://www.snomed.org/snomed-ct their dosages, modes of administration, frequencies, durations, and reasons for administration, in discharge summaries. In our work, we identify only medication mentions. These include names, brand names, generics, and collective names of prescription substances, over-the-counter medications, and other biological substances.
There is a total of 1,249 discharge summaries in the i2b2 dataset. The i2b2 organisers first released a detailed annotation guideline along with a small set of ten annotated summaries. They then challenged the participants to collectively develop the gold standard annotations for 251 summaries which were used as test data. This was to encourage the development of unsupervised or semisupervised methods. Here, we combine all these 261 summaries as labelled data.
Methods

Extended BIO Representation
To deal with discontinuous and overlapping spans, we use an extended version of the standard BIO chunking representation proposed by [MetkeJimenez and Karimi, 2016] . In this representation, four additional prefixes are used: DB, DI, HB, and HI. The following details all the prefixes used in our work together with examples from our data.
O Outside concept. All tokens outside the concepts in which we are interested are labelled as O.
B-Begin of concept, for continuous and nonoverlapping spans.
I-Continuation of concept, for continuous and non-overlapping spans.
DB-Begin of concept, for discontinuous and nonoverlapping spans. For example, in the sentence every joint in my body is in pain, the ADE joint pain is a discontinuous span, so the label for the token joint is DB-ADE.
DI-Continuation of concept, for discontinuous and non-overlapping spans. The label for the token pain in the previous example is DI-ADE.
HB-Begin of concept, for discontinuous and overlapping spans that share one or more tokens with other concepts. For example, in the sentence it has left me feeling exausted, and depressed, two ADEs feeling exausted and feeling depressed overlap and share one common token feeling, so the label of token feeling is HB-ADE.
HI-Continuation of concept, for discontinuous and overlapping spans. The label for the token exausted and depressed in the previous example are both HI-ADE.
Sequence Labelling: CRF and Bi-LSTM Model
We used two different sequence labelling methods: one based on conditional random fields as implemented in Stanford NER (version 3.8.0) [Finkel et al., 2005] and another based on a deep learning method implemented in NeuroNER [Dernoncourt et al., 2017a] . NeuroNER uses Bidirectional LSTM (Bi-LSTM) neural networks. It contains three layers: a character-enhanced tokenembedding layer, a label prediction layer, and a label sequence optimisation layer [Dernoncourt et al., 2017b] . BiLSTMs are known to take into account context from both left and right of a token, and they can handle sequences of variable size. Word embeddings can be provided as input to NeuroNER. To create the embedding, the documents are first tokenised using the spaCy tokeniser 2 . A token will be taken as input of the word embedding layer, and its vector representation will be generated as the output.
Non-Sequence Labelling
A recent work by propose a nonsequence labelling based on the FOFE (FixedSize Ordinally-Forgetting Encoding) representa- tion [Zhang et al., 2015] which they call FOFE-NER. This is using a local detection approach where the left and right contexts of tokens created using FOFE are represented to a deep feedforward neural network. This method is very powerful in capturing immediate dependencies in the tokens and therefore should recognise multiword entities well. We directly apply this method to our problem with all the features that are proposed including character and word level features, to examine its effectiveness in our problem.
Experiments
We experiment using the three methods (CRF, Bi-LSTM, and non-sequence labelling) on the two datasets (CADEC, i2b2 2009) in two settings: (1) an overall comparison of the methods; and (2) an in-depth comparison based on the complexity of the named entities.
These methods are employed using a strategy called one-vs-all in which we train separate models for each entity type. For example, a model to identify drug is created yielding only two kinds of results: drug and not-a-drug.
Different methods of generating word embeddings using Wikipedia, MEDLINE, same corpus, and random embeddings are investigated. In our experiments they all generate similar results given our embeddings were used in a dynamic setting. Dynamic embeddings are re-calculated during the training phase. This is in line with the findings reported in [Karimi et al., 2017] . In the experimental results, we report on random word embeddings.
To evaluate, we run 10-fold cross-validation and report the average scores. Evaluation metrics used here are precision, recall, and F-score, all calculated based on the exact matches of extracted entities with the gold data.
Dataset Entity Method Precision
Recall F-Score CADEC Drug CRF 95.1 ± 2.5 79.1 ± 16.1 85.5 ± 11.4 Bi-LSTM 92.9 ± 2.0 92.2 ± 1.5 92.5 ± 0.7 † Non-sequence Labelling 88.6 ± 4.9 89.8 ± 1.8 89.1 ± 2.1 ADE CRF 67.5 ± 5.1 57.7 ± 2.9 62.1 ± 3.6 Bi-LSTM 73.4 ± 3.9 64.9 ± 4.4 68.7 ± 2.1 † Non-sequence Labelling 62.9 ± 3.8 61.6 ± 1.8 62.1 ± 1.0 i2b2 Drug CRF 93.5 ± 1.0 85.7 ± 2.5 89.4 ± 1.7 Bi-LSTM 93.2 ± 1.2 89.7 ± 1.3 91.4 ± 0.6 † Non-sequence Labelling 84.4 ± 4.2 90.2 ± 2.4 87.1 ± 2.7 Table 3 : Effectiveness of the different methodologies with their standard deviations over 10-fold crossvalidations. Significant differences are shown with a † (p-value< 0.05).
Bi-LSTM
Bi-LSTM 3 7
Non-Seq 3 2315 198 7 1321 2484 CRF 3 7
Non-Seq 3 2333 180 7 916 2889 Table 4 : Comparisons of different methods on the CADEC dataset (ADE entities) based on extracted entities that were correct (3) or incorrect (7).
Sequence Labelling versus Non-Sequence Labelling NER
We compare the two sequence labelling methods, CRF model using Stanford NER and Bi-LSTM-based NER implemented in NeuroNER.
We also compare them with a non-sequence labelling method that uses the FOFE representation [Zhang et al., 2015] (FOFE-NER). Results are shown in Table 3 . On the CADEC dataset, NeuroNER using BiLSTMs perform best for both drug and ADE entities. The only exception is precision for drugs, where the CRF model outperform Bi-LSTM by 2.2%. This is not however statistically significant (Kruskal-Wallis H-test and T-test Non-Seq 3 7317 649 7 296 588 Table 5 : Comparisons of different methods on the i2b2 dataset (drug entities) based on extracted entities that were correct (3) or incorrect (7).
is higher than that of the other two methods, except that CRF and Non-sequence labelling methods show slightly higher results in precision and recall, respectively. The differences, again, are not statistically significant. We then further breakdown these results to identify the overlap between the three methods in terms of correctly identifying NEs, incorrectly identifying them or missing them. This is to determine whether there is the potential in these systems to be used together if the errors they make are different. We show these confusion matrices in Tables 4 and 5 . For CADEC ADEs, there was an almost equal number of both correct and both incorrect cases for all the combinations. This shows the difficulty of extracting the ADEs. The nonsequence labelling method has a larger number of incorrect entities extracted compared to the other two approaches. In the i2b2 dataset (drug entities only), non-sequence labelling makes fewer mistakes that the other systems. We can also infer that these systems are similar (correct or incorrect) in approximately 90% of the time. There is thus a ceiling of 10% that combining the two methods could improve the effectiveness.
Complex Named Entities
In both the CADEC and i2b2 datasets, drug names rarely have overlapping or discontinuous properties. In contrast, it is common for ADEs to be discontinuous or overlapped. 925 out of 6318 ADEs in CADEC are overlapped, while 675 ones are discontinuous. In this section, we focus on the analysis of the effectiveness of the different methods on identifying these discontinuous or overlapped ADEs.
For the first set of experiments, we separate entities based on their complexity: overlapping, discontinuous, continuous multiword, and simple (single word). We then evaluate the output of the NER systems only based on those entities that fall into those categories. Results are shown in Table 6. Note that we mix both entity types of drugs and ADEs. Surprisingly, the CRF method is more successful in identifying overlapping and discontinuous entities. We note that the evaluations are strict: if two entities are overlapped, we expect both to be found to consider the system successful. We use the same strict criteria for the discontinuous entities: If a system only finds one of the two entities, it is not. For CADEC, continuous multiwords are more successfully identified by the nonsequence labelling model, while Bi-LSTM outperforms the other methods for simple entities. Multiwords for the i2b2 dataset do not differentiate the three methods as much, with CRF being slightly better than BiLSTM. Simple entities are equally identifiable for all the three methods too, with a slight win for non-sequence labelling.
One problem for the non-sequence labelling method is its tendency to extract long strings as one entity. For example, in the sentence HORRI-BLE muscle pains, horrible back spasms, spasms in leg muscles, nausea, vomitting, pain so bad that I could hardly walk or sit, the ADE entities are: (1) HORRIBLE muscle pains, (2) horrible back spasms, (3) spasms in leg muscles, (4) nausea, (5) vomitting and (6) pain. These should be extract as separate entities. However, the non-sequence labelling method extracts the sequence of them as one entity which contributes to both one false positive and several false negatives.
Conclusions and Future Work
We presented a comparison of three named entity recognition (NER) methods for extraction of medications and adverse drug events. This is a task important in the context of pharmacovigilance, especially to extract information from consumer reports in health forums. Three methods-CRF, Bi-LSTM, and a non-sequence labelling methodwere chosen based on their popularity, availability, and recency, as well as representing three different approaches to the NER task. We compared these methods based on how they deal with complexity in named entities, that is how they handle entity overlaps and discontinuity, as well as multiwords. Our experiments showed that the non-sequence labelling method can best extract continuous multiword entities, while CRF using Stanford NER is more successful for discontinuous entities.
Our next steps are to verify these results using other biomedical datasets, with different entity and document types. We are also interested in comparing these methods on nested entities which CADEC and i2b2 2009 did not contain. There are other methods that we should investigate, including joint models. Incorporating medical ontologies such as SNOMED CT and MedDRA can also potentially inform a system that deal with biomedical concepts, and in particular adverse events. Other potential methods to investigate are those that incorporate syntactic and semantic parsing of the sentences as well as tree-structure of the entities into account [Finkel and Manning, 2009 , Dinarelli and Rosset, 2011 . Table 6 : Breakdown of the effectiveness of NER methods based on entity complexity.
